Special Offer: Now 25% off original sale price of $1995
Psoriasis has long been a dermatological problem that affects millions of people in the US. Current therapeutic approaches such as lubricants, keratolytic agents and topical corticosteroids have been used for decades. Advances in science offer the potential for actual curative therapy.

This dedicated report from Kalorama Information examines the current and future market for therapeutic agents, including " Natural" approaches in the treatment of psoriasis. Product areas include:

• Current Products/methods
  • Lubricants
  • Keratolytics
  • Topical Corticosteroids
  • Antimetabolites
  • Topical Retinoids
  • UV Treatment
• Advanced/Developmental Approaches
  • Antioxidents
  • An array of monoclonal antibodies
  • Cytokines
  • PVAC
  • Oral Retinoids
  • Others

Market size, segmentation and trends are presented and discussed.

Related Reports:

Electrical and Magnetic Neurostimulation: Applications, Technologies, and Market Potential
Feb 1, 2010 - KLI2495102 - $3,500.00

Kalorama Information Library and Annual Subscription
Jan 1, 2010 - KLI1600708 - $55,000.00

Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
Nov 1, 2009 - KLI2403357 - $3,995.00

The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)
Oct 1, 2009 - KLI2435380 - $3,500.00

Implant-Based Dental Reconstruction: World Dental Implant and Bone Graft Market, 3rd Edition
Sep 1, 2009 - KLI2284095 - $3,500.00

Infectious Disease Diagnostic Markets
Aug 1, 2009 - KLI2391680 - $3,500.00

Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision, 2nd Edition
Jul 1, 2009 - KLI2271479 - $3,500.00

H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)
May 1, 2009 - KLI2241990 - $800.00

The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition
May 1, 2009 - KLI2218043 - $3,995.00

World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)
May 1, 2009 - KLI1829596 - $3,500.00